http://glaucomatoday.com/ The latest news stories from Glaucoma Today. en-us Sun, 9 Jul 2017 17:59:40 GMT Sun, 9 Jul 2017 17:59:40 GMT BMCToday http://glaucomatoday.com/2014/01/28/ocular-therapeutix-receives-fda-approval-for-the-resure-sealant Ocular Therapeutix, Inc., received approval from the FDA to commercialize the ReSure Sealant in the United States, with an indication for preventing postoperative fluid egress from incisions after cataract surgery, according to a company news release. The ReSure Sealant is the first and only sealant that is FDA approve... Tue, 28 Jan 2014 04:00:00 GMT http://glaucomatoday.com/2014/01/28/ocular-therapeutix-receives-fda-approval-for-the-resure-sealant http://glaucomatoday.com/2014/01/28/american-academy-of-ophthalmology-and-american-academy-of-optometry-announce-collaboration The American Academy of Ophthalmology and the American Academy of Optometry announced a joint initiative to work together “in an effort to foster a mutual approach to serving a growing population of patients in the United States who are expected to require eye health services in the near future,” according to a joi... Tue, 28 Jan 2014 04:00:00 GMT http://glaucomatoday.com/2014/01/28/american-academy-of-ophthalmology-and-american-academy-of-optometry-announce-collaboration http://glaucomatoday.com/2014/01/28/ophthalmic-mutual-insurance-company-acknowledges-fda-approved-status-of-mitosol The Ophthalmic Mutual Insurance Company (OMIC) has revised its consent forms related to glaucoma filtering surgery to acknowledge the exclusive FDA-approved status of Mobius Therapeutics’ Mitosol (mitomycin for solution) Kit for ophthalmic use in glaucoma filtering surgery, according to a news release. “This is ... Tue, 28 Jan 2014 04:00:00 GMT http://glaucomatoday.com/2014/01/28/ophthalmic-mutual-insurance-company-acknowledges-fda-approved-status-of-mitosol http://glaucomatoday.com/2014/01/28/aerie-pharmaceuticals-reports-positive-results-for-lead-candidate-ar-13324-in-normotensive-individuals Aerie Pharmaceuticals, Inc., announced top-line results from the company’s recently completed phase 1 pharmacokinetics (PK) study. AR-13324 eye drops were administered once daily to 18 healthy individuals over an 8-day period to assess systemic exposure to the drug, according to a company news release. In addition to... Tue, 28 Jan 2014 04:00:00 GMT http://glaucomatoday.com/2014/01/28/aerie-pharmaceuticals-reports-positive-results-for-lead-candidate-ar-13324-in-normotensive-individuals http://glaucomatoday.com/2014/01/28/ellex-expands-glaucoma-product-offering-through-acquisition-of-canaloplasty-business Ellex Medical Lasers Limited announced that it recently acquired the canaloplasty business of iScience Interventional, Inc., which comprises the iTrack 250 catheter and suture device for the treatment of mild to moderate glaucoma, according to a company news release. “The new canaloplasty business will allow us to ... Tue, 28 Jan 2014 04:00:00 GMT http://glaucomatoday.com/2014/01/28/ellex-expands-glaucoma-product-offering-through-acquisition-of-canaloplasty-business http://glaucomatoday.com/2014/01/28/novel-sustained-release-punctal-plug-lowered-iop A novel sustained-release travoprost punctal (TP; Ocular Therapeutix, Inc.) plug provided a therapeutic benefit in eyes with ocular hypertension or glaucoma for the targeted duration of 60 days, according to data presented by Robert J. Noecker, MD, at the Annual Meeting of the American Academy of Ophthalmology.1 Twe... Tue, 28 Jan 2014 04:00:00 GMT http://glaucomatoday.com/2014/01/28/novel-sustained-release-punctal-plug-lowered-iop http://glaucomatoday.com/2014/01/28/katena-acquires-iop-ophthalmics Katena Products, Inc., has acquired IOP Ophthalmics, Inc., according to a company news release. The terms of the transaction were not disclosed. IOP Ophthalmics develops, commercializes, and distributes ophthalmic surgical devices and biologics. The company offers amniotic membrane technologies for the ocular surface... Tue, 28 Jan 2014 04:00:00 GMT http://glaucomatoday.com/2014/01/28/katena-acquires-iop-ophthalmics http://glaucomatoday.com/2014/01/28/prevent-blindness-america-changes-name Prevent Blindness America announced that it has changed its operating name to Prevent Blindness. According to a news release, the organization is using the new name as a launching pad to refocus efforts around a number of key areas, including awareness of diabetic eye disease, women’s eye health, children’s vision,... Tue, 28 Jan 2014 04:00:00 GMT http://glaucomatoday.com/2014/01/28/prevent-blindness-america-changes-name http://glaucomatoday.com/2014/01/28/zeiss-releases-glaucoma-diagnostic-and-management-application Carl Zeiss Meditec AG announced the US release of the Forum Glaucoma Workplace, a new glaucoma diagnostic and management software application. Available in the Forum data management system, this application supports clinical assessment at the point of care by delivering examination data in new, clinically relevant wa... Tue, 28 Jan 2014 04:00:00 GMT http://glaucomatoday.com/2014/01/28/zeiss-releases-glaucoma-diagnostic-and-management-application http://glaucomatoday.com/2013/11/12/study-identifies-obstacles-to-care-for-vulnerable-adult-population A large proportion of high-risk, uninsured/underinsured individuals do not obtain eye examinations although they screened positive for possible vision problems, according to research published in the Journal of Health Care for the Poor and Underserved.1 To investigate the barriers to care in this population and to f... Tue, 12 Nov 2013 04:00:00 GMT http://glaucomatoday.com/2013/11/12/study-identifies-obstacles-to-care-for-vulnerable-adult-population http://glaucomatoday.com/2013/11/12/wills-eye-glaucoma-service-marks-50th-anniversary The 2013 Wills Eye Ball, held on October 19th, celebrated the 50th anniversary of the Glaucoma Service of Wills Eye Hospital. The event included an international conference and a black tie dinner dance. George L. Spaeth, MD, the founder of Wills’ Glaucoma Service and a leading international glaucoma expert, was hon... Tue, 12 Nov 2013 04:00:00 GMT http://glaucomatoday.com/2013/11/12/wills-eye-glaucoma-service-marks-50th-anniversary http://glaucomatoday.com/2013/11/12/the-glaucoma-foundation-receives-15-million-gift The Glaucoma Foundation (TGF) received a $1.5 million gift commitment from The Gerald and Daphna Cramer Family Foundation. This unrestricted gift, the largest single gift in TGF’s history, will be used to propromote and sustain its mission to find new approaches to understanding and eliminating glaucoma through colla... Tue, 12 Nov 2013 04:00:00 GMT http://glaucomatoday.com/2013/11/12/the-glaucoma-foundation-receives-15-million-gift http://glaucomatoday.com/2013/11/12/mobius-therapeutics-announces-3-million-series-b-funding-to-accelerate-adoption-of-mitosol Mobius Therapeutics, LLC, announced a $3 million Series B round of financing led by capital firm Cultivation Capital. Mobius developed and sells Mitosol, a prepackaged kit containing mitomycin C for glaucoma surgery. According to the company, Mitosol improves the occupational safety of surgeons and hospital staff, prov... Tue, 12 Nov 2013 04:00:00 GMT http://glaucomatoday.com/2013/11/12/mobius-therapeutics-announces-3-million-series-b-funding-to-accelerate-adoption-of-mitosol http://glaucomatoday.com/2013/11/12/leica-microsystems-launches-3-d-surgical-microscopes-with-truevision-technology-inside The first three-dimensional (3-D) surgical microscopes from Leica Microsystems with TrueVision 3-D technology inside are available to customers, according to a news release. By incorporating TrueVision’s digital smart 3-D system inside select models of Leica Microsystems’ surgical microscopes (Leica M720 OH5 and Lei... Tue, 12 Nov 2013 04:00:00 GMT http://glaucomatoday.com/2013/11/12/leica-microsystems-launches-3-d-surgical-microscopes-with-truevision-technology-inside http://glaucomatoday.com/2013/11/12/glaukos-awarded-fierce-15-designation Glaukos Corporation has been named by Fierce Medical Devices as a “Fierce 15” device and diagnostic company of 2013, designating Glaukos as one of the most promising private companies in the medtech space. This is Fierce Medical Devices’ second annual “Fierce 15” selection. “These [15] companies represen... Tue, 12 Nov 2013 04:00:00 GMT http://glaucomatoday.com/2013/11/12/glaukos-awarded-fierce-15-designation http://glaucomatoday.com/2013/11/12/web-based-educational-campaign-for-womens-eye-health Prevent Blindness America recently launched See Jane See—Women’s Healthy Eyes Now, a Web-based educational campaign dedicated solely to women’s vision health. See Jane See and the dedicated website, www.SeeJaneSee.org, offer free information and downloadable tip sheets created specifically for women of all ages ... Tue, 12 Nov 2013 04:00:00 GMT http://glaucomatoday.com/2013/11/12/web-based-educational-campaign-for-womens-eye-health http://glaucomatoday.com/2013/11/12/haag-streit-usa-introduces-new-octopus-perimeter-and-3-d-technology-in-its-surgical-microscopes The new Octopus 600 perimeter from Haag-Streit USA combines early detection and progression monitoring of glaucoma in one compact unit. In addition to standard white-on-white perimetry, the Octopus 600 features Pulsar, a patented flicker stimulus designed to detect glaucoma early, according to a company news release. ... Tue, 12 Nov 2013 04:00:00 GMT http://glaucomatoday.com/2013/11/12/haag-streit-usa-introduces-new-octopus-perimeter-and-3-d-technology-in-its-surgical-microscopes http://glaucomatoday.com/2013/11/12/inotek-pharmaceuticals-raises-21-million-for-ongoing-clinical-development-of-novel-eye-drop Inotek Pharmaceuticals Corporation closed on a $21 million financing, the proceeds of which will be used to advance the company’s lead product, trabodenoson, through phase 2 studies. Trabodenoson is a novel eye drop that reportedly increases aqueous fluid outflow via the trabecular meshwork. According to a news relea... Tue, 12 Nov 2013 04:00:00 GMT http://glaucomatoday.com/2013/11/12/inotek-pharmaceuticals-raises-21-million-for-ongoing-clinical-development-of-novel-eye-drop http://glaucomatoday.com/2013/09/26/as-infections-drop-worldwide-chronic-illness-increases According to the World Bank and the Institute for Health Metrics and Evaluation (IMHE), infectious disease is declining globally, but chronic illness is on the rise. The organizations released reports on September 4, 2013, that present data on six regions of the globe. 1 In August, the IMHE reported that “the burden ... Thu, 26 Sep 2013 04:00:00 GMT http://glaucomatoday.com/2013/09/26/as-infections-drop-worldwide-chronic-illness-increases http://glaucomatoday.com/2013/09/26/allergan-asks-fda-to-revise-guidance-concerning-restasis-generics Allergan, Inc., has asked the FDA to revise its draft guidelines that state that a human clinical trial would not be necessary for a generic drugmaker to establish bioequivalence for Allergan's dry eye disease drug Restasis (cyclosporine ophthalmic emulsion 0.05%), assuming the active ingredient is the same. The FDA o... Thu, 26 Sep 2013 04:00:00 GMT http://glaucomatoday.com/2013/09/26/allergan-asks-fda-to-revise-guidance-concerning-restasis-generics